Promoter Hypermethylation of Apoptotic genes in Oral Squamous Cell Carcinoma

Neha Pal, Shalini Rathore, Priya Kaushik, Swati Tyagi, Abhimanyu Kumar Jha and Anshuman Kumar
Additional contact information
Neha Pal: Department of Biotechnology, Faculty of Life Sciences, Institute of Applied Medicines and Research, Ghaziabad, Uttar Pradesh, India
Shalini Rathore: Department of Biotechnology, Faculty of Life Sciences, Institute of Applied Medicines and Research, Ghaziabad, Uttar Pradesh, India
Priya Kaushik: Department of Biotechnology, Faculty of Life Sciences, Institute of Applied Medicines and Research, Ghaziabad, Uttar Pradesh, India
Swati Tyagi: Department of Biotechnology, Faculty of Life Sciences, Institute of Applied Medicines and Research, Ghaziabad, Uttar Pradesh, India
Abhimanyu Kumar Jha: Department of Biotechnology, Faculty of Life Sciences, Institute of Applied Medicines and Research, Ghaziabad, Uttar Pradesh, India
Anshuman Kumar: Director, Surgical Oncology, Dharamshila Narayana Super speciality Hospital, Delhi, India

Cancer Therapy & Oncology International Journal, 2019, vol. 13, issue 5, 103-108

Abstract: Cancer is one of those diseases whose treatment requires more rapid and potent response and epigenetic modifications have emerged one amongst the cancer hallmarks, commutating the concept of malignant pathologies as being singlely genetic-based conditions. Oral Cancer is the type of malignancy that is found in any area of mouth and nearby regions. The epigenetic landscape is accountable for traditional development however additionally for the non uniformity among tissues in terms of gene expression patterns. Dysregulation in these mechanisms has been related to illness stage, and raised attention is currently granted to cancer so as to require advantage of those modifications in terms of novel therapeutic methods or diagnosis/prognosis tools. Epigenetics has revealed a diagnostic tool that is tumour markers which is also known as biomarkers. These biomarkers are either methylated at their CpG islands called as DNA hypermethylation or another modification could be possibly observed that would help us to identify the neoplasm for its medication because it is usually symptomless at its beginning stages. This review encompasses the different apoptotic genes that have been found as a biomarker for diagnosing the OSCC (Oral Squamous Cell Carcinoma) and how they are related to epigenetics. This can hold an immense importance in the treatment of cancer and could help in discovering novel therapeutic ways in its treatment.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555872.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555872.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:13:y:2019:i:5:p:103-108

DOI: 10.19080/CTOIJ.2019.13.555872

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().